NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit
NÖK Therapeutics to Participate in BIO Investment & Growth Summit in Miami CRANBERRY TOWNSHIP, Pa., March 23, 2026 (GLOBE NEWSWIRE) NÖK Therapeutics, Inc. (“NÖK” or the “Company”), a clinical-stage biotechnology company advancing autologous Natural Killer (“NK”) cell immunotherapies, today announced that…